Octave Specialty (OSG) Common Equity (2010 - 2026)

Octave Specialty's Common Equity history runs 17 years deep, the most recent figure standing at $833.6 million for Q1 2026.

• In Q1 2026, Common Equity fell 13.71% year-over-year to $833.6 million; the TTM figure through Mar 2026 stood at $833.6 million (down 13.71% YoY), while the FY2025 annual figure was $833.2 million, down 16.36% from the prior year.
• Common Equity was $833.6 million for Q1 2026 at Octave Specialty, roughly flat from $833.2 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $1.7 billion in Q3 2024 to a low of $833.2 million in Q4 2025.
• Historically, Common Equity has averaged $1.2 billion across 5 years, with a median of $1.1 billion in 2022.
• The sharpest annual moves came in 2023 and 2025: Common Equity surged 54.02% in 2023, then tumbled 42.57% in 2025.
• A 5-year view of Common Equity shows it stood at $1.3 billion in 2022, then increased by 8.38% to $1.4 billion in 2023, then decreased by 29.58% to $996.1 million in 2024, then slipped by 16.36% to $833.2 million in 2025, then increased by 0.05% to $833.6 million in 2026.
• The last three Common Equity figures came in at $833.6 million (Q1 2026), $833.2 million (Q4 2025), and $959.2 million (Q3 2025), per Business Quant data.